I assume MRK is waiting for OS data and secondary endpoints. I am not sure if MRK would file NDA if it doesn't improve OS.
So, there was anywhere between a 3 week PFS or a couple of months PFS depending on either the DMC results or the clinic results, and, Merck spending probably over $100 million on this trial alone, you actually think Merck wouldn't spend a few million more and file an NDA because they're waiting solely on OS? C'mon, seriously.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.